Rose Cipollone began smoking cigarettes in the 1940s and continued for decades, ultimately developing lung cancer and passing away in 1984. Her husband, as executor, sued several cigarette manufacturers, including Liggett Group, Philip Morris, and Lorillard, in federal court. The complaint alleged multiple state-law theories spanning different time periods: failure to warn; breach of express warranty; fraudulent misrepresentation and concealment; and conspiracy to misrepresent and to neutralize the effect of federally mandated warnings. The defendants asserted that many of these claims were preempted by the Federal Cigarette Labeling and Advertising Act (FCLAA), 15 U.S.C. § 1331 et seq. The 1965 Act required a uniform package warning and contained a limited preemption clause focused on preventing additional statements in advertising. In 1969, Congress strengthened the warning, banned broadcast advertising, and revised § 1334(b) to provide broader preemption of state "requirements or prohibitions based on smoking and health" with respect to "advertising or promotion." Lower courts reached mixed conclusions about the scope of preemption across different claims and time periods. The Supreme Court granted certiorari to resolve how the FCLAA's preemption provisions—particularly the 1969 amendments—apply to common-law damages actions arising from cigarette advertising and promotion.
To what extent does the Federal Cigarette Labeling and Advertising Act, particularly as amended in 1969, preempt state-law damages claims against cigarette manufacturers—such as failure to warn, fraudulent misrepresentation or concealment, conspiracy to misrepresent, and breach of express warranty—based on smoking and health with respect to advertising or promotion?
Express preemption under 15 U.S.C. § 1334 must be interpreted according to statutory text and in light of the presumption against preemption in areas of traditional state regulation. The 1965 Act's preemption provision does not preempt common-law damages actions; it principally bars additional statements in advertising. The 1969 Act's § 1334(b), however, preempts state-law requirements or prohibitions based on smoking and health with respect to the advertising or promotion of cigarettes that comply with federal labeling. Common-law damages duties can constitute "requirements or prohibitions." Claims predicated on a general duty not to deceive (e.g., intentional fraud) or on a manufacturer's own voluntary undertakings (e.g., express warranty) are not preempted, but claims that, in effect, impose additional or different warnings or restrict advertising or promotion on the basis of smoking and health are preempted.
Affirmed in part, reversed in part, and remanded. The 1965 Act does not preempt state common-law damages actions. Under the 1969 Act, state-law failure-to-warn claims and "neutralization" claims are preempted insofar as they rely on omissions or content in cigarette advertising or promotion after the effective date of the 1969 amendments. Breach of express warranty claims are not preempted. Intentional fraud and misrepresentation claims are not preempted to the extent they rest on the general duty not to deceive rather than on a duty to provide additional warnings; conspiracy to misrepresent may likewise proceed to the extent it alleges deceptive conduct independent of any additional warning requirements.
The Court, in a plurality opinion, began with the text and structure of the FCLAA. It applied the presumption against preemption in an area traditionally policed by the states—health and safety via tort law—while emphasizing that Congress can expressly preempt common-law rules. The 1965 Act's preemption provision mainly prohibited additional statements in advertising, and the Court read it as not displacing state common-law damages claims. By contrast, the 1969 amendments materially broadened § 1334(b) to bar any state-law "requirement or prohibition based on smoking and health" with respect to advertising or promotion. The Court accepted that common-law duties enforced by damages awards can indeed function as state "requirements" or "prohibitions," consistent with prior preemption doctrine. The central analytic move was the predicate-duty approach: identifying the specific duty that a state-law claim would impose. Failure-to-warn and neutralization claims for the post-1969 period necessarily sought additional or different warnings, or limits on advertising or promotion, based on smoking and health, and thus fell squarely within § 1334(b)'s express preemption. However, the Court distinguished claims predicated on a general duty not to deceive—such as intentional fraud and misrepresentation—which do not impose an additional warning regime, even if the subject matter concerns smoking and health. Because the state-law predicate is the anti-fraud norm rather than a smoking-and-health-based warning requirement, those claims are not preempted. Similarly, express warranty claims survive because the obligations arise from the manufacturers' own voluntary representations; enforcing those promises is not the imposition of a state requirement "based on smoking and health." The Court further noted that pre-1969 claims and claims not tied to advertising or promotion (as the statute narrowly targets those domains) may proceed. Given the fractured opinions, a majority of the Court converged on these propositions, producing a claim-specific map of preemption.
Cipollone is the foundational case for parsing express preemption clauses in product-regulatory statutes. It establishes that common-law damages actions can be preempted, but only to the extent that their underlying duties fall within the statute's express scope. The decision's predicate-duty framework has become a staple of preemption analysis, guiding courts to ask what the state-law claim actually requires of the defendant and whether that duty intrudes into the federal field. Beyond tobacco litigation, Cipollone's reasoning has influenced cases assessing when fraud, warranty, and failure-to-warn claims survive statutory preemption, and it set the stage for later decisions such as Altria Group v. Good (permitting certain deceptive-marketing claims to proceed) by reinforcing the distinction between state duties to warn and the general duty not to deceive.
Cipollone offers a nuanced, text-driven account of express preemption in a field where Congress sought uniformity in warnings while leaving room for traditional tort principles. By treating common-law damages duties as potential "requirements or prohibitions," the Court acknowledged the real regulatory force of tort law, yet it carefully limited preemption to the statutory terms—advertising or promotion, and duties based on smoking and health.